3D Printed Synthetic Skin Moves Onto a Print Farm

3D printed synthetic skin is no longer only a conference poster in Singapore. On September 17, 2026, TCT reported that UltiMaker signed a memorandum of understanding with Bioactivx to scale on-demand printing of Bioactiv Matrix, a burn dressing the startup already runs on a fleet of desktop-class machines in a certified cleanroom. If you keep a filament printer in a shop, this is the same extrusion idea under a medical quality system — not a garage PLA farm, and not FDA clearance for the United States.

What's Happening

TCT’s September 17 report is the source for the deal and the facility claims. UltiMaker and the Singapore MedTech firm agreed to co-develop a deployable printing solution for regenerative wound care. The announcement sits on two Bioactivx milestones in the same piece: a medical-grade filament line plus cleanroom print farm, and Health Sciences Authority (HSA) approval of Bioactiv Matrix. TCT describes the product as a synthetic, animal-free skin substitute for severe burns that needs no special storage. “Scar-free healing” and faster wound closure are Bioactivx’s stated aims in that article, not an independent clinical trial TCT published.

Production, as TCT tells it, is an end-to-end digital line: the company compounds a proprietary active-ingredient filament in-house, then prints the finished article on UltiMaker hardware inside a certified cleanroom. The same story says the process runs under ISO 13485 and has HSA approval for end-use medical implant manufacturing. Treat ISO 13485 and the implant wording as company/TCT, not a certificate reproduced in the piece. Regulatory submissions for the United States, the EU, Australia, and the rest of ASEAN are ongoing. TCT also notes that Singapore’s HSA is classified as WHO maturity level 4 for medical-device regulation; that ranking describes the agency, not a WHO endorsement of Bioactiv Matrix.

CEO Dr. Peili Teo told TCT the team picked UltiMaker for reliability, ease of use, and open architecture so they could tune a proprietary print process instead of working around a closed stack. UltiMaker CEO Michiel Alting von Geusau called the certification a proof point that UltiMaker platforms can meet standards for certified end-use devices, not only prototypes. The “golden period” after injury, cold-chain avoidance, and distributed manufacturing near the point of need are the companies’ forward pitch. None of those logistics claims include a published time-to-treat table in the TCT article.

Why 3D Printed Synthetic Skin Matters for Print Farms

Hobby and small-shop farms already prove that a row of FFF machines can make the same part overnight. Bioactivx is using that layout for a regulated dressing. The transferable lesson is not “buy a medical spool.” It is that the printer was never the hard part. Filament recipe, environmental control, lot records, and a named quality system are what separate a cleanroom farm from a side-hustle farm. Teo’s open-architecture remark is a process comment: they needed to change the print recipe, not only load a vendor profile.

There is a named research overlap worth flagging without over-claiming. TCT identifies Dr. Peili Teo as Bioactivx CEO. A 2023 ACS Materials Au paper lists Peili Teo as corresponding author on bioactive PLGA dermal scaffolds printed by fused filament fabrication on an Ultimaker S5 at A*STAR in Singapore (Teo et al., 2023). That paper is animal-model work versus Biobrane, not the HSA dossier. It does show that melt-extruded, porous dressings on UltiMaker-class hardware were already a Singapore research path. A garage printer still does not become a wound product because a paper used the same brand of machine.

How 3D Printed Synthetic Skin Differs from a Garage Job

• Feedstock. Bioactivx compounds an active-ingredient medical filament. A shop farm usually melts PLA, PETG, or nylon. Do not swap those in a slicer and call the output a dressing.
• Room. TCT’s photos and copy put the farm in a certified cleanroom. A garage farm is a bench, a dryer, and whatever dust the HVAC allows.
• Records. ISO 13485, as claimed, is a quality-management system for design and production. Hobby farms keep g-code. They do not keep a device master record.
• Regulator. HSA approval is Singapore’s. TCT says US, EU, Australia, and remaining ASEAN filings are still moving. Do not read a .sg clearance as an FDA 510(k).
• Biology. Bioactiv Matrix is described as a synthetic substitute. Living, cell-laden bioprinted grafts are a different process class (Jorgensen et al., 2023).
• Shop takeaway. Use a desktop farm for fixtures, housings, and jigs a med-tech line still needs. Use a certified line for anything that touches a wound.

What the Research Says

Teo, Abbas, Park, and colleagues blended commercial PLGA with bioactive brush copolymers carrying RGD peptide or hyaluronic acid, extruded filament, and printed porous dermal scaffolds on an Ultimaker S5 using Cura. In a porcine partial-thickness burn model they compared those sheets with tulle gras and with Biobrane, a collagen dressing the paper calls a clinical standard for second-degree burns. On day 7, PLGA-RGD 5% showed epidermis regrowth with minimal inflammation, while the negative control had none and Biobrane had only minimal growth. On day 14 a blinded histopathologist scored immune infiltrates at 0+ for PLGA-RGD 5% and 1+ for Biobrane; the authors judged PLGA-RGD 5% and PLGA-HA 10% superior to Biobrane on that porcine series. The paper also notes the PLGA sheets were less elastic, used two staples instead of eight, and often folded by day 3, so actual wound contact may have been three days or less versus seven for Biobrane. That is preclinical work on PLGA scaffolds, not a published Bioactiv Matrix trial (Teo et al., 2023).

Jorgensen, Gorkun, Atala, and colleagues at Wake Forest took the other fork: extrusion bioprinting of six living human cell types into a trilayer epidermis–dermis–hypodermis construct. In mice, bioprinted-skin wounds reached complete closure by day 14 (100% versus about 64% in controls). In pigs, a 5 cm by 5 cm autologous bioprinted graft closed more by epithelialization (60.4% ± 17.1%) and less by contraction than hydrogel-only controls. That is a cell-laden graft that needs culture, not a shelf-stable filament dressing. It is the research reason “print skin” can mean two factories (Jorgensen et al., 2023).

Frequently Asked Questions

What is 3D printed synthetic skin for burn care?

Bioactivx’s Bioactiv Matrix is a 3D printing-enabled synthetic skin substitute for severe burns. TCT reports it uses no animal materials and needs no special storage. The company compounds a proprietary filament and prints it on UltiMaker machines in a certified Singapore cleanroom. HSA approval is Singapore’s; US, EU, Australia, and remaining ASEAN filings are still in progress.

How does a medical 3D printing print farm differ from a hobby farm?

Bioactivx’s farm sits in a certified cleanroom, runs a medical-grade filament line, and TCT says it operates under ISO 13485 for end-use implant manufacturing. A garage farm usually runs commodity PLA or PETG without that quality system. Same extrusion idea, different feedstock, records, and regulator. Do not treat a hobby coupon as a wound dressing.

Can a desktop continuous-fiber printer make medical skin substitutes?

No. Bioactiv Matrix is a regulated product printed from Bioactivx’s own active-ingredient filament on UltiMaker hardware after HSA review. A desktop continuous-fiber printer co-extrudes thermoplastic with carbon or glass tow for brackets and fixtures. Use the bench machine for jigs a med-tech lab still needs, not for replacing a cleanroom dressing line.

Fibricate's Place in This Story

A med-tech print farm still needs stiff plastic around the line: sensor mounts, cart fixtures, and guards that should not wait on a cleanroom queue. Companies like Fibricate, whose FibreSeeker 3 continuous carbon fiber 3D printer can lay a continuous tow from feedstock such as the continuous carbon fiber spool, sit on that bench side of the building. Bioactivx’s product is a regulated dressing on UltiMaker hardware. Keep the lanes separate: certified FFF for the wound article; continuous fiber for the brackets around the farm.

What to Watch Next

Watch whether US, EU, and Australian filings land as device clearances or stall as “ongoing.” Watch whether UltiMaker and Bioactivx publish a deployable cell — machine, filament, and quality pack — or keep production in one Singapore room. Watch how they talk about ISO 13485 in the next 12–24 months: a certificate number is different from a press-line claim. For desktop shops the watch item is smaller. Print farms will keep multiplying. Your machine still earns its keep on parts you can dry, path, and inspect — not on impersonating a wound-care manufacturer.

References & Further Reading

1. Teo, Y. C., Abbas, A., Park, E. J., Barbut, C., Guo, J., Goh, D., Yeong, J. P. S., Mok, W. L. J., & Teo, P. (2023). 3D Printed Bioactive PLGA Dermal Scaffold for Burn Wound Treatment. ACS Materials Au.
2. Jorgensen, A. M., Gorkun, A., Mahajan, N., Willson, K., Clouse, C., Jeong, C. G., Varkey, M., Wu, M., Walker, S. J., Molnar, J. A., Murphy, S. V., Lee, S. J., Yoo, J. J., Soker, S., & Atala, A. (2023). Multicellular bioprinted skin facilitates human-like skin architecture in vivo. Science Translational Medicine.
3. UltiMaker to support Bioactivx in scale-up of 3D printing-enabled synthetic skin substitute. TCT Magazine. Retrieved September 17, 2026.